Inflammation is a highly coordinated biological response initiated when tissues encounter pathogens, damaged cells, toxins, or other harmful stimuli. Its primary purpose is to eliminate the source of injury and initiate tissue repair.

The inflammatory response involves interactions among immune cells, endothelial cells, fibroblasts, epithelial cells, and tissue-resident cells. These cells communicate through cytokines, chemokines, growth factors, lipid mediators, and intracellular signaling pathways.

Under normal circumstances, inflammation is tightly regulated and resolves after the harmful stimulus has been removed. However, excessive or prolonged activation of inflammatory pathways can result in tissue destruction and impaired repair.

Chronic inflammation is associated with numerous human diseases, including atherosclerosis, diabetes, obesity, chronic kidney disease, inflammatory bowel disease, autoimmune disorders, neurodegenerative diseases, and cancer.

At the molecular level, inflammatory signaling begins with recognition of danger-associated or pathogen-associated molecular patterns. Pattern-recognition receptors activate intracellular signaling cascades that ultimately regulate transcription factors and inflammatory mediators.

The NF-κB, MAPK, JAK/STAT, PI3K/Akt, and inflammasome pathways represent major components of this signaling network.

The purpose of this review is to describe the major molecular pathways involved in inflammation and tissue injury and to discuss their contribution to disease development and potential therapeutic targeting.

2. Molecular Recognition of Tissue Injury

Cells recognize tissue injury through specialized receptors capable of detecting molecular signals associated with infection or cellular damage.

These signals include pathogen-associated molecular patterns and damage-associated molecular patterns.

Important pattern-recognition receptor families include:

• Toll-like receptors
• NOD-like receptors
• RIG-I-like receptors
• C-type lectin receptors
• Cytosolic DNA sensors

Activation of these receptors initiates intracellular signaling pathways that regulate inflammatory gene expression.

For example, Toll-like receptor activation can recruit adaptor proteins such as MyD88 and TRIF, ultimately activating NF-κB and MAPK signaling.

The resulting transcriptional response promotes production of cytokines, chemokines, adhesion molecules, and other inflammatory mediators.

3. NF-κB Signaling Pathway

NF-κB is one of the most important transcriptional regulators of inflammation.

The NF-κB family consists of several transcription factors that regulate genes involved in immune responses, cell survival, inflammation, and tissue remodeling.

Under resting conditions, NF-κB proteins are retained in the cytoplasm by inhibitory proteins known as IκBs.

Following inflammatory stimulation, the IκB kinase complex becomes activated and phosphorylates IκB proteins.

Phosphorylated IκB undergoes ubiquitination and degradation, allowing NF-κB to enter the nucleus.

NF-κB then binds regulatory regions of target genes and promotes transcription of inflammatory mediators.

Important NF-κB-regulated molecules include:

• Tumor necrosis factor-alpha
• Interleukin-1β
• Interleukin-6
• Chemokines
• Adhesion molecules
• Cyclooxygenase-2
• Inducible nitric oxide synthase

Persistent NF-κB activation can maintain chronic inflammation and contribute to tissue injury.

4. MAPK Signaling Pathways

Mitogen-activated protein kinases are intracellular signaling proteins that respond to growth factors, cytokines, oxidative stress, and cellular injury.

The major MAPK families include:

1. Extracellular signal-regulated kinases;
2. c-Jun N-terminal kinases;
3. p38 MAP kinases.

MAPK activation occurs through sequential phosphorylation cascades.

The p38 and JNK pathways are particularly important in inflammatory responses.

Activation of MAPKs can regulate transcription factors such as AP-1 and promote expression of inflammatory cytokines and stress-response genes.

MAPK signaling also influences apoptosis, cell proliferation, differentiation, and tissue remodeling.

Excessive MAPK activation may therefore transform a protective inflammatory response into pathological tissue injury.

5. JAK/STAT Signaling

The JAK/STAT pathway is an important mechanism through which extracellular cytokines regulate gene expression.

Cytokines bind their corresponding receptors and activate receptor-associated Janus kinases.

JAK activation results in phosphorylation of STAT proteins.

Phosphorylated STAT proteins form dimers and migrate into the nucleus, where they regulate transcription.

Different STAT proteins respond to different cytokine signals.

For example, STAT3 is involved in inflammatory signaling, cell survival, tissue repair, and metabolic regulation.

STAT1 is strongly associated with interferon-mediated immune responses.

Persistent JAK/STAT activation can contribute to autoimmune inflammation, chronic inflammatory diseases, and cancer.

6. PI3K/Akt Signaling

The PI3K/Akt pathway regulates cell survival, metabolism, proliferation, and inflammatory responses.

Activation of cell-surface receptors can stimulate phosphoinositide 3-kinase, resulting in production of signaling lipids that recruit Akt to the plasma membrane.

Akt activation influences multiple downstream pathways.

In inflammatory cells, PI3K/Akt signaling can regulate cytokine production, cellular metabolism, migration, and survival.

The pathway also interacts with NF-κB and other inflammatory signaling systems.

Consequently, dysregulated PI3K/Akt activity can influence both inflammation and tissue repair.

7. NLRP3 Inflammasome

The inflammasome is a multiprotein intracellular signaling complex that detects cellular stress and danger signals.

Among the best-characterized inflammasomes is the NLRP3 inflammasome.

NLRP3 activation requires multiple cellular signals, including ionic disturbances, mitochondrial dysfunction, reactive oxygen species, and damaged cellular components.

Following activation, the inflammasome promotes activation of caspase-1.

Caspase-1 processes precursor forms of inflammatory cytokines, particularly interleukin-1β and interleukin-18.

Inflammasome activation can also induce pyroptosis, an inflammatory form of programmed cell death.

Excessive NLRP3 activation has been associated with metabolic disease, cardiovascular disorders, inflammatory diseases, and tissue injury.

8. Cytokine Signaling in Tissue Injury

Cytokines are central mediators of inflammation.

Important pro-inflammatory cytokines include:

• TNF-α
• IL-1β
• IL-6
• IL-17
• Interferon-γ

These molecules regulate immune-cell activation, vascular permeability, leukocyte recruitment, fever, acute-phase responses, and tissue remodeling.

TNF-α can activate NF-κB and MAPK pathways, amplifying inflammatory gene expression.

IL-1β promotes leukocyte recruitment and inflammatory mediator production.

IL-6 regulates systemic inflammatory responses and activates JAK/STAT signaling.

Excessive cytokine production can produce tissue injury by promoting oxidative stress, vascular dysfunction, and cell death.

9. Chemokine Signaling and Leukocyte Recruitment

Chemokines are small signaling proteins that guide immune cells toward sites of inflammation.

Chemokine receptors are generally G-protein-coupled receptors located on immune cells.

Chemokine signaling regulates:

• Leukocyte migration
• Chemotaxis
• Cellular adhesion
• Immune-cell activation
• Tissue infiltration

Although leukocyte recruitment is essential for tissue defense, excessive recruitment can result in collateral tissue damage.

Neutrophils, macrophages, and other immune cells can release proteases, reactive oxygen species, and inflammatory mediators that damage surrounding tissues.

10. Oxidative Stress and Inflammatory Signaling

Oxidative stress represents an important connection between inflammation and tissue injury.

Activated immune cells can produce reactive oxygen species as part of antimicrobial defense.

However, excessive ROS can damage cellular proteins, lipids, DNA, and membranes.

ROS can also activate inflammatory signaling pathways, including NF-κB and inflammasome pathways.

Mitochondrial dysfunction may further increase ROS production.

This creates a feedback loop in which inflammation increases oxidative stress, while oxidative stress stimulates additional inflammatory signaling.

11. Role of Mitochondria in Inflammation

Mitochondria are not only energy-producing organelles but also important regulators of inflammatory signaling.

Damaged mitochondria can release mitochondrial DNA, ATP, cardiolipin, and other molecules that function as danger signals.

These signals can activate inflammatory pathways and inflammasomes.

Mitochondrial dysfunction can also increase reactive oxygen species generation.

Therefore, mitochondrial injury may contribute to persistent inflammation and tissue damage.

12. Inflammasome-Mediated Tissue Injury

Inflammasomes provide a mechanism for detecting intracellular danger signals.

Although inflammasome activation is important for host defense, excessive activation can contribute to pathological inflammation.

Activated caspase-1 promotes maturation of IL-1β and IL-18.

Pyroptosis can additionally release intracellular inflammatory components into the surrounding tissue.

This process can amplify local inflammation and recruit additional immune cells.

Inflammasome activity has been implicated in metabolic disorders, cardiovascular disease, liver injury, kidney disease, and neuroinflammatory conditions.

13. Apoptosis and Tissue Injury

Apoptosis is a regulated form of cell death that generally occurs without the extensive inflammatory response associated with necrosis.

However, excessive apoptosis can contribute to tissue loss and impaired organ function.

Mitochondrial pathways can initiate apoptosis through release of cytochrome c and activation of caspases.

Inflammatory signaling can influence apoptotic pathways, while dying cells can release signals that affect surrounding immune cells.

The balance between cell survival and cell death is therefore critical for tissue homeostasis.

14. Pyroptosis and Inflammation

Pyroptosis is an inflammatory form of programmed cell death.

It is associated with activation of inflammatory caspases and gasdermin proteins.

Following activation, gasdermin-mediated membrane pore formation results in cell swelling and membrane disruption.

This allows intracellular inflammatory mediators to enter the extracellular environment.

Pyroptosis has an important role in host defense but may contribute to pathological tissue injury when excessive.

15. Necroptosis

Necroptosis is a regulated form of necrotic cell death.

It is mediated primarily through signaling involving receptor-interacting protein kinases and mixed lineage kinase domain-like protein.

Unlike conventional apoptosis, necroptosis results in membrane disruption and release of intracellular danger signals.

These signals can activate neighboring immune cells and promote secondary inflammation.

Necroptosis has been implicated in inflammatory, infectious, cardiovascular, and neurological diseases.

16. Inflammation and Endothelial Dysfunction

The vascular endothelium plays a central role in regulating leukocyte recruitment and vascular permeability.

Inflammatory cytokines can activate endothelial cells and increase expression of adhesion molecules.

These molecules facilitate attachment and migration of leukocytes into tissues.

Excessive endothelial activation can increase vascular permeability and promote tissue edema.

In chronic inflammation, endothelial dysfunction may contribute to vascular injury and cardiovascular disease.

17. Inflammation and Fibrosis

Persistent inflammation can stimulate fibroblast activation and excessive extracellular matrix deposition.

Transforming growth factor-beta is an important regulator of fibrosis.

Chronic inflammatory signaling can increase production of collagen and other extracellular matrix proteins.

Fibrosis can progressively disrupt tissue architecture and reduce organ function.

This mechanism contributes to chronic liver disease, kidney disease, pulmonary fibrosis, and cardiac remodeling.

18. Inflammation in Metabolic Diseases

Inflammatory signaling contributes substantially to metabolic disorders.

In obesity, adipose tissue can become infiltrated by immune cells and develop chronic low-grade inflammation.

Inflammatory cytokines can interfere with insulin signaling and promote insulin resistance.

NF-κB and JNK pathways are particularly relevant to inflammatory metabolic dysfunction.

Persistent inflammation can consequently contribute to type 2 diabetes, fatty liver disease, and cardiovascular complications.

19. Inflammation and Cardiovascular Disease

Inflammation contributes to the initiation and progression of atherosclerosis.

Endothelial dysfunction promotes recruitment of monocytes into the vascular wall.

Monocytes differentiate into macrophages, which can accumulate modified lipids and contribute to formation of atherosclerotic plaques.

Inflammatory cytokines and matrix-degrading enzymes can weaken plaque structures.

Excessive inflammatory activity may therefore increase the risk of plaque rupture and cardiovascular events.

20. Inflammation in Neurodegenerative Disorders

Neuroinflammation is increasingly recognized as an important component of neurodegenerative disease.

Microglia and astrocytes respond to damaged neurons and abnormal protein accumulation.

Persistent activation of these cells can increase production of cytokines, chemokines, ROS, and other inflammatory mediators.

Chronic neuroinflammation may therefore contribute to neuronal dysfunction and degeneration.

Inflammatory signaling has been investigated in Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological disorders.

Review Design

The present article was prepared as a narrative review examining molecular signaling pathways associated with inflammation and tissue injury.

Literature Search

Scientific literature was reviewed using biomedical databases and peer-reviewed scientific journals.

Search terms included combinations of:

“inflammation,” “tissue injury,” “NF-κB,” “MAPK,” “JAK/STAT,” “PI3K/Akt,” “NLRP3 inflammasome,” “cytokines,” “chemokines,” “oxidative stress,” “pyroptosis,” “necroptosis,” “apoptosis,” “fibrosis,” and “inflammatory signaling.”

Inclusion Criteria

Studies were considered relevant when they:

• Investigated molecular inflammatory signaling;
• Examined tissue injury mechanisms;
• Described inflammatory transcription factors;
• Investigated cytokine or chemokine pathways;
• Examined inflammasome activation;
• Investigated programmed cell death; or
• Evaluated therapeutic approaches targeting inflammatory signaling.

Exclusion Criteria

Publications without substantial relevance to molecular inflammation, tissue injury, or intracellular signaling mechanisms were excluded from the principal synthesis.

Data Synthesis

Evidence was organized according to major inflammatory signaling pathways and their relationships with oxidative stress, immune-cell activation, cellular death, fibrosis, and tissue remodeling.

22. Results

The reviewed evidence demonstrates that inflammation and tissue injury are regulated by interconnected molecular signaling networks rather than by a single pathway.

The major findings can be summarized as follows:

1. Pattern-recognition receptors initiate intracellular signaling following detection of pathogens or tissue damage.
2. NF-κB represents a major transcriptional regulator of inflammatory gene expression.
3. MAPK pathways regulate inflammatory transcription, stress responses, cellular proliferation, and apoptosis.
4. JAK/STAT signaling provides an important mechanism through which cytokines regulate gene expression.
5. PI3K/Akt signaling influences cell survival, metabolism, immune-cell activity, and inflammatory responses.
6. Inflammasomes regulate maturation of important inflammatory cytokines and can initiate pyroptosis.
7. Oxidative stress and mitochondrial dysfunction amplify inflammatory signaling.
8. Excessive activation of inflammatory pathways contributes to tissue destruction, fibrosis, vascular dysfunction, and chronic disease.

These observations demonstrate that inflammation is controlled through extensive molecular cross-talk, and dysregulation at multiple points can sustain pathological tissue injury.

23. Therapeutic Perspectives

NF-κB Inhibition

Because NF-κB regulates numerous inflammatory genes, inhibition of this pathway represents an attractive therapeutic strategy.

However, complete suppression may interfere with normal immune defense.

Future approaches should therefore focus on selective modulation rather than broad inhibition.

MAPK-Targeted Therapy

Inhibitors of p38, JNK, and other MAPK components have been investigated for inflammatory diseases.

The therapeutic challenge is achieving sufficient pathway inhibition while preserving physiological cellular responses.

JAK Inhibitors

JAK inhibitors can interfere with cytokine signaling by preventing activation of downstream STAT proteins.

This approach has demonstrated therapeutic potential in several immune-mediated diseases.

Inflammasome Inhibition

Targeting inflammasome activation may reduce excessive production of IL-1β and IL-18.

Selective inhibition of NLRP3 and associated inflammatory mechanisms is an active area of research.

Antioxidant Strategies

Because oxidative stress amplifies inflammatory signaling, antioxidant strategies may provide complementary therapeutic benefits.

However, excessive suppression of physiological ROS signaling may also interfere with normal cellular functions.

Modulation of Cell Death

Therapeutic modulation of apoptosis, pyroptosis, and necroptosis may help limit tissue injury.

The challenge is to prevent pathological cell death while preserving appropriate elimination of damaged or infected cells.

Inflammation is an essential protective response, but its effectiveness depends on precise regulation.

The molecular signaling pathways described in this review form a highly interconnected network.

NF-κB and MAPK pathways frequently operate together following receptor activation. Their interaction allows cells to rapidly respond to microbial and tissue-derived danger signals.

Cytokine-mediated JAK/STAT signaling adds another layer of regulation by allowing extracellular inflammatory signals to directly modify transcription.

Meanwhile, inflammasomes provide an intracellular mechanism for detecting cellular stress.

These pathways do not function independently. Instead, they communicate through feedback mechanisms.

For example, NF-κB activation can promote production of inflammasome components and inflammatory cytokines. Mitochondrial dysfunction can increase ROS production, which can stimulate both NF-κB and inflammasome signaling.

Inflammatory cytokines can subsequently further impair mitochondrial function, creating a self-sustaining cycle.

This molecular interaction helps explain why acute inflammation can transition into chronic inflammation.

The consequences of prolonged inflammatory signaling extend beyond immune activation. Persistent inflammation can alter vascular permeability, disrupt metabolic signaling, activate fibroblasts, and promote cell death.

In metabolic diseases, inflammatory signaling contributes to insulin resistance and lipid abnormalities. In cardiovascular disease, it promotes endothelial dysfunction and atherosclerotic plaque development. In neurological disorders, persistent activation of microglia and astrocytes may contribute to neuronal injury.

Another important mechanism is fibrosis. When inflammatory signaling persists, tissue repair mechanisms may become dysregulated. Increased transforming growth factor-beta signaling and extracellular matrix deposition can progressively replace functional tissue with fibrotic material.

Therefore, controlling inflammation requires more than simply suppressing individual cytokines. Therapeutic approaches should ideally restore the balance between inflammatory activation, resolution, tissue repair, and immune defense.

An important challenge is that the same signaling pathway may have beneficial or harmful effects depending on disease stage and cellular context.

For example, NF-κB activation is necessary for normal host defense but pathological when persistently activated.

Similarly, inflammasome activation contributes to antimicrobial defense but can promote tissue injury when excessive.

Future therapies will therefore need to achieve precise temporal and tissue-specific regulation.

25. Future Perspectives

Future research should focus on understanding the spatial and temporal organization of inflammatory signaling.

Advanced single-cell and spatial molecular technologies may allow researchers to identify which cell populations initiate inflammation and which maintain chronic tissue injury.

Another important research direction involves identifying biomarkers capable of distinguishing protective inflammation from pathological inflammation.

Integration of transcriptomic, proteomic, metabolomic, and epigenetic information may provide a more comprehensive understanding of inflammatory networks.

Precision medicine approaches may eventually allow therapies to be selected according to the dominant inflammatory pathway in individual patients.

Development of selective inhibitors targeting specific components of NF-κB, MAPK, JAK/STAT, inflammasome, and cell-death pathways may improve therapeutic efficacy while reducing adverse effects.

Greater understanding of inflammation-resolution pathways is also necessary. Rather than simply suppressing inflammation, future strategies may aim to actively promote resolution and restoration of tissue homeostasis.

Inflammation and tissue injury are controlled by complex molecular signaling networks involving pattern-recognition receptors, NF-κB, MAPK, JAK/STAT, PI3K/Akt, inflammasomes, cytokines, chemokines, oxidative stress pathways, and regulated cell-death mechanisms.

These pathways coordinate immune responses and tissue repair under normal conditions. However, persistent or excessive activation can result in oxidative damage, cellular death, endothelial dysfunction, fibrosis, and chronic tissue injury.

Molecular interactions between inflammatory signaling, mitochondrial dysfunction, oxidative stress, and cell death create feedback mechanisms capable of maintaining pathological inflammation.

Understanding these mechanisms provides important opportunities for identifying disease biomarkers and developing targeted therapies.

Future therapeutic strategies should focus on selective modulation of inflammatory pathways while preserving essential host-defense and tissue-repair functions. A detailed understanding of molecular signaling networks will be essential for developing more effective treatments for chronic inflammatory and tissue-injury disorders.

1. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–435.
2. Lawrence T. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspectives in Biology. 2009;1:a001651.
3. Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Research. 2011;21:223–244.
4. Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. Nature Reviews Immunology. 2013;13:679–692.
5. O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity. 2012;36:542–550.
6. O'Shea JJ, Schwartz DM, Villarino AV, Gadina M, McInnes IB, Laurence A. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annual Review of Medicine. 2015;66:311–328.
7. Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170:605–635.
8. Swanson KV, Deng M, Ting JPY. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nature Reviews Immunology. 2019;19:477–489.
9. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. International Journal of Molecular Sciences. 2019;20:3328.
10. Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunological Reviews. 2018;281:8–27.
11. Medzhitov R. The spectrum of inflammatory responses. Cold Spring Harbor Perspectives in Biology. 2013;5:a016408.
12. Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140:871–882.
13. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxidants & Redox Signaling. 2014;20:1126–1167.
14. Tait SWG, Green DR. Mitochondria and cell signalling. Journal of Cell Science. 2012;125:807–815.
15. Galluzzi L, Vitale I, Aaronson SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death & Differentiation. 2018;25:486–541.
16. Galluzzi L, Vitale I, Warren S, et al. The hallmarks of cancer. Cell. 2023;186:243–278.
17. Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunological Reviews. 2015;265:130–142.
18. Newton K, Manning G. Necroptosis and inflammation. Annual Review of Biochemistry. 2016;85:743–763.
19. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nature Medicine. 2012;18:1028–1040.
20. Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nature Reviews Immunology. 2013;13:349–361.
21. Tabas I, Garcia-Cardeña G, Owens GK. Recent insights into the cellular biology of atherosclerosis. Journal of Cell Biology. 2015;209:13–22.
22. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867.
23. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metabolism. 2012;15:635–645.
24. Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nature Reviews Immunology. 2014;14:463–477.
25. Ward PA. The acute inflammatory response and its regulation. Archives of Surgery. 1999;134:666–669.